Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804999 · ClinicalTrials.gov registry record · NA
Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure
A NA study of Normal Contact Lens Wear, sponsored by Christine Sindt.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT00804999: Completed NA study of Normal Contact Lens Wear, sponsored by Christine Sindt.
NCT00804999 is a NA study of Normal Contact Lens Wear that has completed, run by Christine Sindt. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804999, a NA study of Normal Contact Lens Wear, has completed, sponsored by Christine Sindt.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess the usefulness of using confocal microscopy to examine changes to the structure of the cornea and to identify any potential consequences of contact lens wear and/or solution use.
Primary Outcome
Looking for cell density
Conditions Studied
Interventions
- DRUG Clear Care
- DRUG ReNu
- DRUG OPTI-FREE
Study Locations (1)
Iowa
- University of Iowa Contact Lens Clinic - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2008-11-01 |
| Est. Completion | 2009-03-01 |
| Phase | NA |
What the finished NCT00804999 record still lists
NCT00804999 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Normal Contact Lens Wear appearing as the primary indexed condition, and to 3 interventions - of which Clear Care is the first listed.
NCT00804999 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT00804999 about?
NCT00804999 is a clinical study titled "Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure". Assess the usefulness of using confocal microscopy to examine changes to the structure of the cornea and to identify any potential consequences of contact lens wear and/or solution use.
What is the current status of trial NCT00804999?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2008-11-01. Estimated completion is 2009-03-01.
What conditions does trial NCT00804999 study?
This clinical trial studies the following conditions: Normal Contact Lens Wear.
What interventions are being tested in trial NCT00804999?
The interventions under investigation include: Clear Care (DRUG), ReNu (DRUG), OPTI-FREE (DRUG).
Who is sponsoring clinical trial NCT00804999?
This trial is sponsored by Christine Sindt, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00804999 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00804999's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI